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Abstract 1 
Background: Whether obesity phenotypes measured by different anthropometric indices are 2 
associated with a risk of colorectal adenocarcinoma by anatomical location is unclear.  3 
Patients and Methods: A collection of harmonized population-based cohort studies (Cohort 4 
of Norway, CONOR) with 143,477 participants was conducted between 1994 and 2010. 5 
General, abdominal, gluteofemoral obesity, and other type were assessed by body mass index 6 
(BMI), waist circumference, hip circumference (HC), and body adiposity index (BAI) 7 
adjusted by BMI or/and waist circumference. Cox proportional hazards regression was 8 
performed to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of obesity 9 
relative to a risk of colorectal adenocarcinoma. 10 
 11 
Results: In total, 2044 incident cases of colorectal adenocarcinoma were identified. We 12 
observed a positive association between WC (≥86(women) or ≥96(men) versus<75(women) 13 
or <88 (men)) and adenocarcinoma in the proximal colon (HR 1.92, 95% CI: 1.47-2.50) and 14 
distal colon(HR 1.71, 95% CI: 1.25-2.33) when adjusted for BMI. The association with WC 15 
was especially evident in men. BMI was not associated with adenocarcinoma in the colon or 16 
rectum after adjusting for WC. No associations were found between HC and colorectal 17 
adenocarcinoma. When adjusted by BMI plus WC, BAI was negatively associated with 18 
adenocarcinoma in the proximal or distal colon  19 
 20 
Conclusion: Abdominal, not general or gluteofemoral obesity, was associated with an 21 
increased risk of adenocarcinoma in the proximal and the distal colon, especially in men. 22 
Muscularity may be negatively associated with risk of adenocarcinoma in the proximal colon. 23 
Key words: Anthropometrics; Waist circumference; Abdominal obesity; Muscularity; 24 
Adenocarcinoma; Colon; Rectum; CONOR; HUNT 25 
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Introduction 51 
General obesity (measured using body mass index (BMI)) and abdominal or central obesity 52 
(measured by waist circumference) increases the risk of colorectal cancer.
1-3
 The risk of 53 
colorectal cancer associated with obesity is also influenced by sex, age, menopausal status, 54 
and ethnicity.
4-7
 However, direct measurements of subcutaneous and visceral obesity by 55 
computer tomography (CT) have shown inconsistent results.
8-10
 It is conceivable, therefore, 56 
that the causal relation between obesity and colorectal cancer may not be as simple as 57 
assumed. In addition to different environmental conditions and hereditary factors, the 58 
selection of anthropometric indices to substitute phenotypes of obesity may have profound 59 
effects on the prediction of colorectal cancer risk. 60 
 61 
Several anthropometric indices for the measurement of obesity have been developed and 62 
applied in epidemiological studies. As the most commonly used anthropometric parameter, 63 
BMI is a good index for general obesity, but not sensitive for more specific obese 64 
phenotypes, e.g. abdominal obesity.
11
 The latter is widely recognized as the key factor related 65 
to diabetes, cardiovascular diseases, and cancer.
12,13
 Waist circumference and waist to hip 66 
ratio have been demonstrated as two important indices for abdominal obesity.
11
 Waist to 67 
height ratio ( or called waist to stature ratio) has been associated with cardiovascular diseases 68 
as a new parameter of abdominal obesity, but reports on colorectal cancer are rare.
14,15
 Hip 69 
circumference has been suggested as a measurement of gluteofemoral obesity, which has 70 
been negatively associated with a risk of chronic diseases, including cancer.
16
 As a newly 71 
developed anthropometric parameter, waist to height index (WHI) was associated with an 72 
increased risk of colorectal cancer in female Japanese subjects, but no further study has been 73 
reported.
17
 Another newly introduced anthropometric parameter, body adiposity index (BAI), 74 
has been recognized as an index ofestimating percentage of body fat, but the largely 75 
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inconsistent results achieved with body adiposity index warrant more explorations of this 76 
index. 77 
 78 
Collectively, a series of anthropometric parameters, representing specific obesity phenotypes, 79 
have been developed during the past decades, but few studies have compared these 80 
anthropometric indices and how they are associated differently with colorectal cancer risk by 81 
anatomical location. 82 
 83 
In the present study, the association between different anthropometric indices for obesity and 84 
colorectal adenocarcinoma by anatomical location were investigated in a large, prospective, 85 
population-based cohort study in Norway: the CONOR study. Since adenocarcinoma is the 86 
dominating histological type (more than 90%) and different histological types of colorectal 87 
cancer may entail different causality, only the risk of adenocarcinoma has been assessed in 88 
the current study. 89 
 90 
Materials and Methods 91 
Study population 92 
Detailed information on the design of, and data collection in, the CONOR study has been 93 
described previously.
18
 Briefly, CONOR was performed in collaboration between the 94 
Norwegian Institute of Public Health and the Universities of Bergen, Oslo, Tromsø, and 95 
Trondheim (NTNU). Data from 10 regional epidemiological studies were merged into a 96 
national database to study risk factors for a wide range of diseases. In total,180,553 97 
participants from 10 epidemiology studies were included in the CONOR study.
19
After 98 
excluding repeated participants (7310 with two follow-ups), prevalent cancer cases (906), 99 
individuals who died or migrated before the baseline survey (6075), missing waist 100 
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circumference, hip circumference, height or weight data (21234), and missing smoking data 101 
(1551), a total of 143,477 participants remained for the final analysis. Anthropometric data 102 
were harmonized throughout all the studies based on common questionnaires/similar clinical 103 
measurements. 104 
 105 
Follow-up and identification of colorectal cancer cases 106 
The CONOR cohort was followed-up based on linkage to the Norwegian Cancer Register 107 
(NCR) and Statistics Norway, using the unique 11-digit national identity number of 108 
Norwegian citizens. Colorectal cancer was registered in the NCR according to the 109 
International Classification of Diseases, 7th edition (ICD-7). The ICD-7 codes were used to 110 
identify the colorectal cancer cases by anatomical location, including: the proximal colon 111 
(ICD-7 codes 1530, 1531, and 1536, including the cecum, ascending colon, transverse colon, 112 
hepatic flexure, the splenic flexure and appendix); the distal colon (ICD-7 codes 1532 and 113 
1533, including the descending colon, the sigmoid colon); the rectum(ICD-7 code 1540, 114 
including the rectum and rectosigmoid junction). The participants were enrolled into the 115 
cohort at the baseline until diagnosis of colorectal cancer, death, censored (i.e. lost to follow-116 
up, emigration or diagnosis of other malignancies), or end of follow-up on December 31, 117 
2010, whichever occurred first. 118 
 119 
Assessment of anthropometric data 120 
Body weight (in kilograms(kg), to one decimal place) and height (in centimeters(cm), to one 121 
decimal place) were manually recorded until the year 2000 and thereafter an electronic height 122 
and weight scale was used. BMI was calculated as body weight (kg) divided by the square of 123 
height(meters square). Waist circumference was measured at the umbilicus to the nearest 124 
centimeter and with the subject standing and breathing normally. Hip circumference was 125 
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measured as the maximum circumference around the buttocks. Waist to hip ratio and waist to 126 
height ratio was calculated from measurements of waist circumference, hip circumference or 127 
height. Waist to height index was calculated by the formula of waist circumference 128 
(cm)/height (m)/height (m).
17
 The body adiposity index was computed by the formula of (hip 129 
circumference(cm)/height(meter)
1.5
)-18. 130 
 131 
We examined each obesity phenotype with one specific anthropometric index. BMI was used 132 
for general obesity, waist circumference for abdominal obesity, hip circumference for 133 
gluteofemoral obesity, and body adiposity index for one uncertain type. Due to the limited 134 
space of the manuscript and also in order to complement the results using other related 135 
indices, the results of waist to hip ratio, waist to height ratio and waist to height index were 136 
further showed in supplemental tables.  137 
 138 
Other data collected at the baseline survey included: marital status, country of birth, years of 139 
education, smoking, alcohol consumption, physical activity, anti-hypertensive drug use, and 140 
self-reported diabetes. 141 
 142 
Statistical analysis 143 
Hazard ratios (HRs) and 95% confidence intervals (95% CIs) for the association between the 144 
anthropometric indices and colorectal cancer were estimated using Cox proportional hazard 145 
models. BMI was grouped into four categories (<22.5, 22.5-25, 25-30, >30 kg/m
2
). The 146 
categorization of BMI was slightly different from the WHO standardization because of small 147 
size of cohort members in the group of BMI less than 18.5. Waist circumference was divided 148 
into three categories based on sex-specific cut-offs (women: <75, 75-85.9, ≥86; men <88, 88-149 
95.9, ≥96 cm). Hip circumference was categorized into two groups (<101 cm and ≥101 cm), 150 
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and waist to height ratio three groups (<0.5, 0.5- and ≥0.6). Other anthropometric data were 151 
analyzed based on continuous variables. Waist to hip ratio and waist to height ratio were 152 
multiplied by 10 in the model to decrease the significant fluctuation of the small values, and 153 
are interpreted as 1/10 change. WHI was divided by 10 and was interpreted as a per 10 units 154 
increase, while body adiposity index was divided by 5 and interpreted as a per 5 units 155 
increase.   156 
 157 
Analyses of BMI were conducted with and without adjustment for waist circumference. The 158 
analyses of waist circumference, hip circumference, waist to hip ratio, waist to height ratio, 159 
and waist to height index were performed both with and without inclusion of BMI in the 160 
models.
20
 Body adiposity index was analyzed with adjustment for BMI or/and waist 161 
circumference. An interaction between sex and anthropometric indices (BMI, waist 162 
circumference, waist to height ratio, and waist to height index) was found.  Therefore, further 163 
sex-stratified analyses of anthropometric measurements were performed. P values for trend 164 
were computed based on continuous variables of median values of categories of BMI, waist 165 
circumference, or waist to height ratio.    166 
 167 
Compared with weight and height, waist circumference and hip circumference had a 168 
significant number of missing values (20,902 in total) because both were not measured in 169 
1994, the first round of the survey. We analyzed the data based on three approaches. First, we 170 
removed all of the participants with missing waist circumference or hip circumference data. 171 
Second, we imputed waist circumference based on a sex-specific model adjusted for age, sex, 172 
smoking, alcohol drinking, education, physical activity, height and weight. Third, we 173 
analyzed the data when using missing waist circumference as a separate category. Since the 174 
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overall results were not changed materially, we kept results based on the first approach in the 175 
main report. 176 
For each anthropometric indicator, we analyzed data based on a crude model adjusted for age 177 
and sex and a multivariable model adjusted for all potential confounders, but we only 178 
reported the results based on multivariable models because the overall results were not 179 
changed. We selected confounders based on previous etiological studies on colorectal cancer 180 
together with stepwise selection approaches. The following co-variables were included in the 181 
multivariable model: age (<50, 50-60, ≥60), education (none/primary school/secondary 182 
school, high school, university), currently daily smoking (yes, no), alcohol drinking 183 
(never/seldom, several times per week, about once a week, 2-3 times per month, about once a 184 
month), physical activity (none, <1,1-2, ≥3 hours/week). There are approximately 10% to 185 
20% missing values for education, alcohol drinking and physical activity. We treated the 186 
missing values as a separate category or deleted them from the total dataset for analyses. 187 
Since the final results did not materially alter, we only included the results based on missing 188 
values as separate categories in order to keep as many participants and colorectal cancer cases 189 
as possible for the whole study. Furthermore, we excluded the first two years of follow-up in 190 
order to decrease the potential bias of reverse causality; the results were similar and are not 191 
shown.  192 
 193 
The proportional hazards assumption was tested on the basis of Schoenfeld residuals 194 
afterfitting a Cox regression model. None of the variables violated the assumption except for 195 
the age groups. The age groups were, thus, treated as a strata factor in the model. A two-sided 196 
test with a significance level (α) of 0.05 was chosen. All analyses were performed using SAS 197 
9.3 for Windows (SAS Institute Inc., Cary, NC, USA).  198 
 199 
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Ethics 200 
The present study was approved by the Regional Committee for Medical and Health 201 
Research Ethics, Central Norway (ID: 2012/853/REK midt). The individual studies included 202 
in CONOR were all approved by their respective ethics committees. All participants signed 203 
an informed consent form. 204 
 205 
Results 206 
Basic characteristics 207 
During an average of 11.3 years of follow-up, 2044 incident cases of colorectal 208 
adenocarcinoma(853 in the proximal colon, 606 in the distal colon and 555 in the rectum, 30 209 
cases with specified locations) were identified.  Of these cases, 1101 (54 %) were men and 210 
943 (46 %) were women (Table 1). The average age at study entry was 64.5 years for cases 211 
and 50.9 years for non-cases.  Cases were less educated (35.3% of cases versus 22.6% of the 212 
total cohort in the lowest education categ3ory), had more family history of cancer (32.9% 213 
versus 25.3%), less physical activity (10.9% versus 6.3% for 3 or more hours per week) and 214 
alcohol drinking (13% versus 12% for drinking alcohol several times per week), whereas 215 
daily smoking seemed to be more common in the total cohort members (Table 1).  216 
 217 
General obesity (body mass index, BMI) and colorectal adenocarcinoma  218 
The highest BMI category (BMI>30) was associated with colorectal adenocarcinoma when 219 
the multivariable models were not adjusted for waist circumference (HR 1.17, 95% CI: 1.02-220 
1.34), but the association disappeared when the models were adjusted for waist circumference 221 
(HR 0.90, 95% CI: 0.76-1.06)(Table 2). The risk estimates were similar for each anatomical 222 
location within the colon and rectum (Table 2). Interestingly, a negative association of BMI 223 
with proximal colon adenocarcinoma was observed when adjusted for waist circumference 224 
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(HR 0.77, 95%CI: 0.59-0.99, Table 2). This association was attenuated in the sex-stratified 225 
analyses but still existed, especially in women (Table 3).  226 
 227 
Abdominal obesity (waist circumference) and colorectal adenocarcinoma 228 
Waist circumference(cm, ≥86(women) or ≥96(men) versus  <75(women) or <88 (men))was 229 
positively associated with adenocarcinoma of the proximal and the distal colon (HR 1.51, 230 
95%CI: 1.24-1.83 and HR 1.48, 95% CI: 1.18-1.86, respectively), and the association became 231 
stronger when the model was adjusted for BMI (HR 1.92, 95% CI: 1.47-2.50 and HR 1.71, 232 
95% CI: 1.25-2.33, respectively)(Table 2). For the rectum, no association was observed (HR 233 
1.16, 95% CI: 0.93-1.46; HR 1.12, 95% CI: 0.82-1.54, with or without adjustment for BMI, 234 
respectively).The positive association between waist circumference and adenocarcinoma of 235 
the proximal and distal colon was evident in both sexes, especially in men (Table 3).A 236 
positive association was further observed for rectal adenocarcinoma in women (HR 2.07, 237 
95%: 1.17-3.68) (Table 3).  238 
 239 
Gluteofermoral obesity (hip circumference) and colorectal adenocarcinoma 240 
Positive associations were found between HC(<101 cm versus ≥101) and adenocarcinoma in 241 
the proximal and the distal colon (HR 1.23, 95% CI: 1.07-1.42; HR 1.19, 95%CI: 1.01-1.40, 242 
respectively), but not in the rectum (HR 1.03, 95% CI: 0.87-1.22) (Table 2).These 243 
associations were more evident in men (Table 3), but disappeared with adjustments for BMI 244 
plus waist circumference (Table 2). 245 
 246 
Body adiposity index (BAI) and colorectal cancer 247 
Body adiposity index was not associated with colorectal adenocarcinoma (HR 0.98, 95%CI: 248 
0.93-1.04)(Table 2). However, when the analyses were further adjusted for BMI or BMI plus 249 
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waist circumference, negative associations were observed for adenocarcinoma of the 250 
proximal and the distal colon (adjustment for BMI, HR 0.88, 95%CI: 0.78-0.99; HR 0.81, 251 
95%CI: 0.70-0.94) (Table 2).  252 
 253 
BMI and waist circumference 254 
All of the results in this section were analyzed based on a comparison with the normal BMI 255 
(22.5-25kg/m
2
) and lower waist circumference category (women <80cm, men <94cm). In the 256 
low BMI category (<22.5 kg/m
2
), higher waist circumference indicated an increased risk of 257 
colorectal adenocarcinoma, especially in the proximal colon and rectum. The latter was a 258 
surprisingly increased HR which was not observed in the aforementioned analyses (HR 2.37; 259 
95%CI: 1.09-5.12), however, only seven cases of rectal adenocarcinoma were identified in 260 
this group. In the normal BMI group, HR are 1.31 (95%CI: 0.95-1.80) and 1.44 (95%CI: 261 
0.97-2.14) for proximal colon and distal colon respectively when a higher waist 262 
circumference compared to the lower category.  (Table 5).  In the overweight group (BMI 25-263 
30kg/m
2
), a higher waist circumference displayed an elevated risk of colon adenocarcinoma, 264 
especially in the distal colon, but not the rectum. Similar high circumference results can be 265 
found in the obese group (BMI≥30 kg/m2) (Table 5), but a lower circumference may still 266 
entail an increased risk of adenocarcinoma in the proximal colon (HR), although the results 267 
were not statistically significant due to too few cases.  268 
 269 
Other anthropometric indices and colorectal adenocarcinoma 270 
Waist to hip ratio (per 1/10 increase) was positively associated with adenocarcinoma in the 271 
proximal and distal colon (HR 1.28, 95%CI: 1.16-1.42 and HR 1.20, 95%CI:1.06-1.36, 272 
respectively), and the associations remained almost similar when adjusted for BMI 273 
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(Supplemental Table 1). In the sex-stratified analyses, positive associations remained for the 274 
proximal colon in both sexes(Supplemental Table 1).  275 
 276 
Waist to height ratio (per 1/10 increase) was positively associated with adenocarcinoma in 277 
the proximal colon regardless of adjustment for BMI (HR 1.18, 95%CI: 1.06-1.31; HR 1.26, 278 
95%CI: 1.07-1.49, with or without adjustment for BMI) (Supplemental Table 1). This 279 
association remained for categorical variables of Waist to height ratio (Supplemental Table 280 
1). No association was observed for adenocarcinoma in the rectum, regardless of adjustment 281 
for BMI (Table 2). In the sex-stratified analysis, a persistent association with colon 282 
adenocarcinoma was observed in men, especially in the proximal colon(Supplemental Table 283 
1). 284 
 285 
WHI was associated with adenocarcinoma in the proximal colon (HR1.18, 95%:1.01-1.39) 286 
but this association disappeared when adjusted for BM I (Supplemental Table 1). Similar 287 
results could be found in the sex-stratified analysis (Supplemental Table 2). 288 
 289 
Discussion 290 
Abdominal obesity, represented by waist circumference, waist to hip ratio, or waist to height 291 
ratio, seemed to be the most important obesity phenotype that had the strongest association 292 
with adenocarcinoma in the proximal and the distal colon, but no association with 293 
adenocarcinoma in the rectum. General obesity, represented by body mass index (BMI), 294 
seemed to not be associated with colorectal adenocarcinoma when adjusted for abdominal 295 
obesity. While gluteofemoral obesity, represented by hip circumference, was not associated 296 
with colorectal adenocarcinoma. 297 
 298 
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The strengths of the current study included the large population-based cohort design with a 299 
long follow-up period, where anthropometric measures were objectively assessedby standard 300 
protocols rather than being self-reported. Potential confounders such as smoking, consuming 301 
alcohol, education, and physical activity were adjusted for as well. The Norwegian Cancer 302 
Register and Statistics Norway provided outcomes of cancer and death with a high validity. 303 
Weaknesses of the study included the possibility of residual confounding produced by 304 
missing information of nutrients/diet. For missing values, we performed sensitivity analyses 305 
based on imputation, deletion, or treating as a separate category. The overall results, however, 306 
were consistent and conclusions were not changed. We also realize that the anthropometric 307 
measures of abdominal obesity may not separate visceral obesity from subcutaneous fat.  308 
Each of them probably have different effects on cancer incidence, while visceral fat may be 309 
worse. Nevertheless, the mutual adjustment of waist circumference and BAI may provide 310 
more evidence for this issue.  311 
 312 
General and abdominal obesity have been associated with colorectal cancer in many studies. 313 
In a large European cohort study, obesity was associated with a higher relative risk of cancer 314 
in the colon than cancer of the rectum
20
. This is consistent with our results. However, whether 315 
general or abdominal obesity played the leading role was not clear in the previous studies.
20,21
 316 
In our study, abdominal adiposity (mainly determined by waist circumference, waist to hip 317 
ratio or waist to height ratio) was statistically associated with colon cancer especially in men 318 
irrespective of BMI. On the other hand, BMI was not associated with colon cancer when 319 
adjusted for waist circumference. This suggests that abdominal adiposity is a more important 320 
risk factor for colon cancer than general adiposity. However, as Hu et al. pointed out, in a 321 
disease model with waist circumference and BMI, waist circumference would still reflect 322 
abdominal adiposity, but BMI would probably be more a measure of lean body mass since 323 
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body fatness is to a large extent accounted for by waist circumference, especially in older 324 
adults
11
. This might well explain the negative association of BMI with the proximal colon 325 
adenocarcinoma when the analysis was adjusted for waist circumference. On the other hand, 326 
for a given BMI, individuals with an elevated waist circumference will likely have more 327 
abdominal fat and, thus, more visceral, liver, and ectopic fat and therefore a higher risk of 328 
obesity-related metabolic disorders. In the sex-stratified analyses, a positive association of 329 
waist circumference with adenocarcinoma in the proximal and distal colon persisted, 330 
especially in men. This is consistent with the study from a Chinese cohort. 
22
Surprisingly, a 331 
strongly positive association of waist circumference with rectal adenocarcinoma in women 332 
was observed. A positive, but not strong association, was also observed for waist to hip ratio 333 
or waist to height ratio with female rectal adenocarcinoma. As this has been rarely reported in 334 
previous studies, further evidence is warranted. When we examined the risk of colorectal 335 
adenocarcinoma for a given BMI and waist circumference, we found a consistently increased 336 
risk of abdominal obesity represented by a higher waist circumference regardless of lower or 337 
normal BMI, overweight, or obesity. This further strengthened our conclusion regarding the 338 
pivotal role of abdominal obesity on adenocarcinoma in the proximal and distal colon.  339 
 340 
There is increasing evidence that the anatomical position of adipose tissue determines the 341 
effects on the individual and predicts the associated morbidity from cancer.
16,23
This has led to 342 
the addition of the new anthropometric indices of obesity in addition to BMI and waist 343 
circumference. Gluteofemoral body fat, assessed by hip circumference, is associated with a 344 
protective lipid and glucose profile, as well as a decrease in cardiovascular and metabolic 345 
risk.
24
 However, the association between hip circumference and cancer is inconclusive.
25,26
 346 
The present study found that an increasing hip circumference was associated with an 347 
increased risk of adenocarcinoma of the colon, while this association disappeared with 348 
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additional adjustments for BMI and waist circumference. This indicates that gluteofemoral 349 
obesity is not associated with colorectal cancer. Furthermore, since BMI cannot reflect the 350 
percentage of body fat (e.g., with a high BMI may be due to lean muscular mass rather than 351 
body fat), the body adiposity index  has therefore been purposely developed. In our study, 352 
body adiposity index was negatively associated with adenocarcinoma in the proximal and the 353 
distal colon when adjusted for BMI or BMI plus waist circumference. This seemed to be 354 
similar to the association between BMI and colorectal adenocarcinoma. If this reflects the 355 
true association, body adiposity index may indicate the percentage of muscular mass for a 356 
given BMI or BMI plus waist circumference, because BMI or waist circumference has 357 
represented the body fat. Since body adiposity index was still an anthropometric index under 358 
debate, this result may need further validating studies. 359 
 360 
Other anthropometric indices have also been investigated in previous studies. Waist to height 361 
ratio is associated with cancer and cardio-metabolic risks.
27,28
 In a study among Taiwanese 362 
adults, a Waist to height ratio >0.5 was an indicator of centralized obesity, even among 363 
‘healthy’ individuals according to BMI and waist circumference.29 A recent systemic review 364 
and meta-analysis also demonstrated that waist to height ratio is a better screening tool for 365 
adult cardiometabolic risk factors than waist circumference and BMI.
27
 As far as we know, 366 
no data has been reported about the association between waist to height ratio and colorectal 367 
cancer. In our study, we found a consistent association between waist to height ratio and an 368 
increased risk of adenocarcinoma of the proximal and distal colon, but not the rectum. 369 
Moreover, waist to height ratio is a simple and easily understood anthropometric index, 370 
which may carry much valuable public health implications, e.g., waist to height ratio may 371 
allow the same boundary values (0.5) for children and adults, women and men.
30
 As a newly 372 
developed index, waist to height index (WHI is a composite index proposed by a Japanese 373 
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study.
17
 In our study, however, waist to height index  (per 10 units of increase) was not 374 
associated with an increased risk of colorectal adenocarcinoma. 375 
 376 
Abdominal fat is comprised of fat stored subcutaneously (e.g., subcutaneous adipose tissue) 377 
and the adipose tissue located in the abdominal cavity. The latter has been commonly 378 
described as intra-abdominal or visceral adipose tissue. Visceral adiposity is the best 379 
adiposity predictor of liver fat content which is closely related to features of metabolic 380 
syndrome. Abdominal obesity, metabolic syndrome, insulin resistance and modifications in 381 
levels of adipocytokines seem to be of great importance for the underlying mechanisms 382 
linking obesity to colorectal cancer, whichis certainly a multifactorial process.
3
 Adipose 383 
tissue is a highly active tissue that secrets various cytokines, chemokines, and hormones.
31
 384 
Some of these cytokines can act directly in the promotion of cancer.
13,32
 Circulating insulin 385 
levels increase with obesity and many obese patients are insulin resistant. Chronic 386 
hyperinsulinemia decreases insulin growth factor binding proteins 1 and 2, resulting in an 387 
increase in circulating insulin and, more importantly, insulin growth factor. This in turn 388 
results in decreased apoptosis and increased cell proliferation in the target tissues.
23
 Studies 389 
have shown a correlation of an elevated C-peptide (a surrogate of circulating insulin) with 390 
colorectal cancer.
32
 Furthermore, adipokines (leptin and adiponectin) secreted by adipose 391 
tissue have been associated with carcinogenesis.
33,34
 Leptin is apro-inflammatory hormone 392 
and has also been shown to be directly tumorigenic. Adiponectin levels, which are decreased 393 
in obese individuals, are associated with a lower risk of colorectal cancer.
33,34
  Further 394 
carcinogenesis has been proposed for obesity-driven low-grade inflammation. Inflammatory 395 
cells are present in abundance in visceral adipose tissue and the secretion of inflammatory 396 
mediators into the body creates a chronic inflammatory state that is thought to generate a pro-397 
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tumorigenic environment.
31
 Systemic pro-inflammatory markers, such as C-reactive protein 398 
and interleukin-6, are elevated in the obese due to obesity-driven low-grade inflammation.
13
 399 
 400 
In conclusion, obesity, especially abdominal obesity, was positively associated with 401 
adenocarcinoma of the proximal and distal colon, but not certainly with the rectum. Obesity 402 
control, with a focus on abdominal obesity, will be an important factor in the prevention of 403 
malignancy of the colon.  404 
 405 
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Table 1. Characteristics of colorectal adenocarcinoma cases and cohort members in CONOR  
  
Variables Cohort participants 
Colorectal  
Adenocarcinoma 
Colon 
Rectum 
Proximal colon Distal colon 
Total 143477 2044 853 606 555 
Sex, n(%) 
     
Men 70033(49) 1101(54) 410(48) 332(55) 343(62) 
Women 73444(51)  943(46) 443(52) 274(45) 212(38) 
      
Age at examination 
     
Mean (SD
a
)  50.9(16) 64.5(12)  65.8(11) 63.4(12) 63.5(12) 
Age by groups (%) 
     
<50 81232(57) 341( 17) 119(14) 117(19) 103(19) 
50-59 17559(12) 269(13) 96(11) 91(15) 80(14) 
≥60 44686(31) 1434(70) 638(75) 398(66) 372(67) 
Education, n(%) 
     
None/primary school/secondary school 32423(23) 724(35) 320(38) 198(33) 198(36) 
High school 44964(31) 468(23) 193(22) 136(22) 134(24) 
University 29227(20) 237(12) 88(10) 94(16) 51(9) 
Missing 36863(26) 615(30) 252(30) 178(29) 172(31) 
      
Smoking status, n(%) 
     
Not daily smoker 101341(71) 1542(75) 653(77) 461(76) 402(72) 
2 
 
Daily smoker 42136(29) 502(25) 200(23) 145(24) 153(28) 
      
Alcohol consumption last year, n(%) 
     
Never/seldom 41694(29) 690(34) 316(37) 182(30) 185(33) 
About 1-3 times per month 45233(32) 465(23) 174(20) 149(25) 135(24) 
About once a week 26106(18) 331(16) 123(14) 116(19) 89(16) 
Several times per week 17187(12) 265(13) 104(13) 77(13) 80(14) 
Missing 13257(9) 293(14) 136(16) 82(13) 66(13) 
      
Physical activity, n(%) 
     
None 43492(30) 720(35) 318(37) 225(37) 167(30) 
Less than once a week  30222(21) 342(17) 117(14) 108(18) 113(20) 
1-2 hours per week 28226(20) 284(14) 113(13) 86(14) 84(15) 
3 or more hours per week  15581(11) 129(6) 49(6) 41(7) 36(7) 
Missing 25956(18) 569(28) 256(30) 146(24) 155(28) 
      
b
Family history of cancer, n(%) 36309(25) 672(33) 385(33) 211(35) 169(31) 
Diabetes, n(%) 4463(4) 122(6) 57(7) 31(5) 33(6) 
c
Cardiovascular diseases, n(%) 11373(8) 301(15) 137(16) 78(13) 81(15) 
Asthma, n(%) 12087(8) 210(10) 99(12) 62(10) 46(8) 
      
Body mass index (BMI), mean (SD) 26.2(4.1) 27.0(4.1)  27.1(4.1) 27.0(4.0) 27.0(4.1) 
Waist circumference (cm), mean (SD) 86.9(12.1) 90.7(11.8) 90.6(12.2) 90.6(11.5) 91.0(11.5) 
Hip circumference (cm), mean (SD) 101.6(7.8) 102.7(7.6) 102.9(7.8) 102.8(7.4) 102.5(7.5) 
Waist to hip ratio*10 (WHR), mean (SD) 8.5(0.9) 8.8(0.9) 8.8(0.9) 8.8(0.9) 8.9(0.8) 
3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Waist to height ratio*10 (WHtR), mean (SD) 5.1(0.7) 5.3(0.7) 5.4(0.7) 5.3(0.6) 5.3(0.6) 
Waist to height index, (WHI) mean (SD) 30.1(4.5) 31.6(4.4) 31.9(4.5) 31.3(4.2) 31.4(4.3) 
Body adiposity index (BAI), mean (SD) 27.9(4.9) 28.4(4.7) 29.2(5.1) 28.4(4.7) 28.3(5.0) 
a: SD, standard deviation 
b. Family history of cancer: self-reported cancer among parents, siblings and children 
c. Cardiovascular diseases: including angina pectoris, myocardial infarction and stroke. 
1 
 
Table 2. HR and 95% CI for risk of colorectal adenocarcinoma in relation to anthropometric characteristics 
Anthropometric indices 
Colorectal adenocarcinoma by anatomical location
a 
Total Proximal colon Distal colon Rectum 
  HR(95%CI)   HR(95%CI)   HR(95%CI)   HR(95%CI) 
Total 2044 
 
853 
 
606 
 
 
555 
Overall obesity:  
           Body mass index (BMI)      
   Not adjusted for waist circumference 
     
   <22.5 234 0.97(0.82-1.14) 97 0.95(0.74-1.21) 72 1.06(0.79-1.42) 60 0.87(0.64-1.19) 
22.5-25 435 Reference 181 Reference 122 Reference 127 Reference 
25-30 942 1.03(0.92-1.15) 389 1.01(0.85-1.21) 286 1.13(0.91-1.39) 251 0.94(0.76-1.16) 
>30 433 1.17(1.02-1.34) 186 1.15(0.93-1.41) 126 1.26(0.98-1.62) 117 1.14(0.88-1.47) 
P value for trend 
 
0.008 
 
0.11 
 0.10  
0.13 
      
 
  
Adjusted for waist circumference 
     
   <22.5 234 1.08(0.91-1.28) 97 1.10(0.84-1.43) 72 1.23(0.90-1.68) 60 0.91(0.66-1.26) 
22.5-25 435 Reference 181 Reference 122 Reference 127 Reference 
25-30 942 0.88(0.77-1.00) 389 0.80(0.65-0.98) 286 0.94(0.74-1.19) 251 0.90(0.71-1.15) 
>30 433 0.90(0.76-1.06) 186 0.77(0.59-0.99) 126 0.94(0.69-1.29) 117 1.07(0.78-1.49) 
P value for trend 
 
0.17 
 
0.04 
  0.37  
 0.41 
      
 
  
Abdominal obesity:  
             Waist Circumference (cm)      
   Not adjusted for BMI 
     
   <75(women) or <88 (men) 388 Reference 148 Reference 111 Reference 120 Reference 
75-85.9(women) or 88-95.9(men) 699 1.16(1.02-1.31) 281 1.17(0.96-1.43) 214 1.27(1.01-1.60) 195 1.08(0.86-1.36) 
≥86(women) or ≥96(men) 957 1.37(1.22-1.55) 424 1.51(1.24-1.83) 281 1.48(1.18-1.86) 240 1.16(0.93-1.46) 
P value for trend 
 
<.0001 
 
<.0001 
 
0.0006 
 
 0.19 
      
 
  
Adjusted for BMI 
     
   <75(women) or <88 (men) 388 Reference 148 Reference 111 Reference 120 Reference 
75-85.9(women) or 88-95.9(men) 699 1.26(1.09-1.46) 281 1.34(1.07-1.69) 214 1.42(1.08-1.85) 195 1.09(0.84-1.43) 
2 
 
≥86(women) or ≥96(men) 957 1.56(1.32-1.84) 424 1.92(1.47-2.50) 281 1.71(1.25-2.33) 240 1.12(0.82-1.54) 
P value for trend 
 
<.0001 
 
<.0001 
 
0.001 
 
0.49 
   
      Gluteofemoral obesity  
            Hip circumference (cm)      
   Not adjusted for BMI 
     
   <101 816 Reference 322 Reference 237 Reference 238 Reference 
≥101 1227 1.14(1.04-1.25) 531 1.23(1.07-1.42) 368 1.19(1.01-1.40) 317 1.03(0.87-1.22) 
Adjusted for BMI 
     
   <101 816 Reference 322 Reference 237 Reference 238 Reference 
≥101 1227 1.12(1.00-1.25) 531 1.28(1.07-1.53) 368 1.16(0.94-1.43) 317 0.95(0.77-1.18) 
Adjusted for BM and waist circumference 
     
   <101 816 Reference 322 Reference 237 Reference 238 Reference 
≥101 1227 1.02(0.90-1.15) 531 1.12(0.93-1.35) 368 1.05(0.84-1.30) 317 0.92(0.73-1.15) 
      
 
  
      
 
  
Muscularity 
          Body adiposity index (BAI, continuous, per 5 units) 
 
    
 
  
Not adjusted for BMI or waist circumference 2043 0.98(0.93-1.04) 853 0.98(0.91-1.07) 605 0.95(0.86-1.06) 555 1.03(0.92-1.15) 
Adjusted for BMI 2043 0.87(0.81-0.94) 853 0.88(0.78-0.99) 605 0.81(0.70-0.94) 555 0.95(0.81-1.10) 
Adjusted for waist circumference 2043 0.88(0.83,0.94) 853 0.86(0.78,0.95) 605 0.84(0.74,0.95) 555 0.99(0.88,1.13) 
Adjusted for BMI and waist circumference 2043 0.86(0.80-0.94) 853 0.87(0.77-0.98) 605 0.81(0.70-0.93) 555 0.94(0.81-1.10) 
a. adjusted for education, smoking status, alcohol drinking, physical activity, family history of cancer, study center, and/or anthropometrics when appropriate, stratified by age groups.  
 
 
 
 
 
Table 3. HR and 95% CI for risk of colorectal adenocarcinoma in relation to anthropometric 
characteristics in men 
Anthropometric indices 
Total Proximal colon Distal colon Rectum 
N HR(95%CI) N HR(95%CI) N HR(95%CI) N HR(95%CI) 
Body mass index (BMI) 
      
Not adjusted for waist circumference 
       
<22.5 86 0.89(0.69-1.14） 31 0.86(0.57-1.30) 23 0.86(0.54-1.39) 30 0.91(0.60-1.38) 
22.5-25 238 Reference 88 Reference 66 Reference 81 Reference 
25-30 561 1.02(0.87-1.19) 207 1.01(0.79-1.30) 176 1.16(0.87-1.54) 169 0.90(0.69-1.18) 
30 216 1.30(1.08-1.57) 84 1.37(1.01-1.85) 67 1.48(1.05-2.09) 63 1.11(0.79-1.54) 
P value for trend 
 
0.002 
 
0.03 
 
0.009 
 
0.59 
         
Adjusted for waist circumference 
       
<22.5 103 0.96(0.74-1.24) 31 1.02(0.66-1.57) 23 1.03(0.63-1.70) 36 0.87(0.56-1.34) 
22.5-25 279 Reference 88 Reference 66 Reference 94 Reference 
25-30 644 0.91(0.76-1.08) 207 0.77(0.58-1.02) 176 0.98(0.72-1.35) 205 0.97(0.72-1.31) 
30 246 1.08(0.86-1.36) 84 0.86(0.59-1.25) 67 1.20(0.79-1.83) 75 1.26(0.82-1.92) 
P value for trend 
 
0.59 
 
0.39 
 
0.52 
 
0.25 
         
Waist Circumference (cm) 
      
Not adjusted for BMI 
        
<75(women) or <88 (men) 216 Reference 70 Reference 54 Reference 86 Reference 
75-85.9(women) or 88-95.9(men) 364 1.16(0.98-1.38) 125 1.23(0.92-1.65) 120 1.55(1.12-2.14) 116 0.93(0.70-1.23) 
≥86(women) or ≥96(men) 521 1.37(1.17-1.61) 215 1.73(1.31-2.28) 158 1.71(1.24-2.34) 141 0.93(0.71-1.23) 
P value for trend 
 
<.0001 
 
<.0001 
 
0.002 
 
0.65 
         
Adjusted for BMI 
        
<75(women) or <88 (men) 216 Reference 71 Reference 54 Reference 86 Reference 
75-85.9(women) or 88-95.9(men) 364 1.20(1.00-1.46) 129 1.39(1.00-1.95) 120 1.57(1.09-2.27) 116 0.90(0.65-1.24) 
≥86(women) or ≥96(men) 521 1.37(1.10-1.70) 217 2.05(1.41-2.97) 158 1.62(1.06-2.45) 141 0.82(0.57-1.20) 
P value for trend 
 
0.01 
 
<.0001 
 
0.05 
 
0.31 
         
Hip circumference (cm)  
      
Not adjusted for BMI 
        
<101 419 Reference 141 Reference 124 Reference 145 Reference 
≥101 682 1.21(1.07-1.37) 269 1.41(1.15-1.73) 208 1.24(0.99-1.56) 198 1.02(0.82-1.26) 
Adjusted for BMI 
        
<101 419 Reference 141 Reference 124 Reference 145 Reference 
≥101 682 1.14(0.99-1.32) 269 1.39(1.09-1.78) 208 1.09(0.83-1.42) 198 0.99(0.76-1.28) 
              Adjusted for BMI and waist circumference 
      
<101 419 Reference 141 Reference 124 Reference 145 Reference 
≥101 682 1.07(0.92-1.25) 269 1.20(0.92-1.56) 208 0.99(0.75-1.31) 198 1.04(0.79-1.38) 
  
   
    
Body adiposity index (BAI, continuous, per 5 units) 
  
    
Not adjusted for BMI or waist 
circumference 
1101 1.07(0.97-1.18) 410 1.12(0.95-1.31) 332 1.08(0.90-1.30) 343 1.02(0.85-1.22) 
Adjusted for BMI 1101 0.94(0.83-1.07) 410 0.97(0.79-1.20) 332 0.88(0.70-1.11) 343 0.96(0.76-1.21) 
Adjusted for BMI and waist circumference 1101 0.94(0.83-1.07) 410 0.97(0.79-1.19) 332 0.89(0.70-1.12) 343 0.96(0.76-1.22) 
 
Table 4. HR and 95% CI for risk of colorectal adenocarcinoma in relation to anthropometric 
characteristics in women 
Anthropometric indices 
        
N HR(95%CI) N HR(95%CI) N HR(95%CI) N HR(95%CI) 
Body mass index (BMI) 
      
Not adjusted for waist ircumference 
        
<22.5 148 1.00(0.81-1.24) 66 0.98(0.71-1.34) 49 1.14(0.77-1.67) 30 0.83(0.53-1.32) 
22.5-25 197 Reference 93 Reference 56 Reference 46 Reference 
25-30 381 1.05(0.89-1.25) 182 1.02(0.79-1.31) 110 1.11(0.80-1.54) 82 1.02(0.71-1.47) 
30 217 1.09(0.89-1.32) 102 1.01(0.76-1.35) 59 1.11(0.76-1.61) 54 1.24(0.83-1.86) 
P value for trend 
 
0.36 
 
0.8 
 
0.91 
 
0.104 
         
Adjusted for waist circumference 
        
<22.5 180 1.15(0.91-1.46) 66 1.11(0.79-1.57) 49 1.27(0.83-1.93) 30 1.04(0.63-1.73) 
22.5-25 229 Reference 93 Reference 56 Reference 46 Reference 
25-30 422 0.87(0.71-1.05) 182 0.84(0.64-1.12) 110 0.91(0.63-1.30) 82 0.82(0.55-1.23) 
30 245 0.77(0.60-0.99) 102 0.72(0.50-1.04) 59  0.76(0.47-1.21) 54 0.88(0.53-1.48) 
P value for trend 
 
0.007 
 
0.04 
 
0.08 
 
0.54 
         
Waist Circumference (cm) 
      
Not adjusted for BMI 
        
<75(women) or <88 (men) 172 Reference 78 Reference 57 Reference 34 Reference 
75-85.9(women) or 88-95.9(men) 335 1.16(0.96-1.40) 156 1.12(0.85-1.47) 94 1.03(0.74-1.44) 79 1.47(0.98-2.21) 
≥86(women) or ≥96(men) 436 1.40(1.16-1.68) 209 1.33(1.02-1.74) 123 1.31(0.94-1.82) 99 1.78(1.19-2.67) 
P value for trend 
 
0.0002 
 
0.03 
 
0.07 
 
0.01 
         
Adjusted for BMI 
        
<75(women) or <88 (men) 172 Reference 78 Reference 57 Reference 34 Reference 
75-85.9(women) or 88-95.9(men) 335 1.33(1.06-1.65) 156 1.27(0.92-1.76) 94 1.21(0.82-1.81) 79 1.63(1.01-2.63) 
≥86(women) or ≥96(men) 436 1.81(1.39-2.36) 209 1.75(1.19-2.58) 123 1.78(1.10-2.88) 99 2.07(1.17-3.68) 
P value for trend 
 
<.0001 
 
0.003 
 
0.01 
 
0.02 
         
Hip circumference (cm)  
      
Not adjusted for BMI 
        
<101 397 Reference 181 Reference 113 Reference 93 Reference 
≥101 545 1.09(0.95-1.24) 262 1.10(0.91-1.34) 160 1.16(0.91-1.49) 119 1.07(0.81-1.41) 
Adjusted for BMI 
        
<101 397 Reference 181 Reference 113 Reference 93 Reference 
≥101 545 1.08(0.90-1.29) 262 1.16(0.89-1.50) 160 1.29(0.92-1.80) 119 0.86(0.59-1.26) 
Adjusted for BMI and waist circumference 
      
<101 397 Reference 181 Reference 113 Reference 93 Reference 
≥101 545 0.96(0.80-1.16) 262 1.04(0.79-1.37) 160 1.16(0.81-1.65) 119 0.75(0.51-1.11) 
 
   
     
Body adiposity index (BAI, continuous, per 5 units) 
  
    Not adjusted for BMI or waist 
circumference  
0.96(0.90-1.03) 
 
 0.95(0.86-1.05) 273 0.92(0.81-1.05) 
 
1.07(0.93-1.23) 
Adjusted for BMI 
 
0.86(0.77-0.95) 
 
0.87(0.75-1.01) 273 0.82(0.67-1.00) 
 
0.94(0.76-1.17) 
Adjusted for BMI and waist circumference   0.84(0.75-0.93)   0.85(0.73-0.99) 273 0.79(0.65-0.97)   0.92(0.74-1.14) 
 
1 
 
 
Table 5. HR and 95% CI for risk of colorectal adenocarcinoma in relation to normal weight obesity 
     
Body Mass index (BMI, 
kg/m2)   
Waist circumference 
(cm) 
Non-cases 
participants 
Colorectum Proximal colon Distal colon Rectum 
Cases HR(95%CI) Cases HR(95%CI) Cases HR(95%CI) Cases HR(95%CI) 
Lower weight (<22.5) Women<80, men<94 23559 218 1.00(0.84-1.19) 90 1.00(0.76-1.31) 70 1.19(0.87-1.64) 53 0.80(0.58-1.12) 
Women≥80, men≥94 937 16 1.47(0.89-2.43) 7 1.42(0.66-3.06) 2 0.70(0.17-2.87) 7  2.37(1.09-5.12) 
Normal weight (≥22.5 and 
<25) 
Women<80, men<94 28671 320 Reference 128 Reference 87 Reference 101 Reference 
Women≥80, men≥94 6920 115 1.23(0.99-1.53) 53 1.31(0.95-1.80) 35 1.44(0.97-2.14) 26 0.97(0.63-1.50) 
Over weight(≥25 and <30) 
Women<80, men<94 23004 273 0.97(0.82-1.14) 88 0.80(0.61-1.06) 85 1.10(0.82-1.49) 94 1.02(0.77-1.35) 
Women≥80, men≥94 37440 669 1.13(0.99-1.30) 301 1.21(0.98-1.49) 201 1.30(1.01-1.68) 157 0.88(0.69-1.14) 
Obese (≥30) 
Women<80, men<94 443 5 1.07(0.44-2.58) 4 2.22(0.82-6.02) 1  0.77(0.11-5.55) 0 0 
Women≥80, men≥94 22503 428 1.25(1.08-1.44) 182 1.23(0.98-1.55) 125  1.41(1.06-1.86) 117 1.16(0.88-1.52) 
a: normal weight without abdominal obesity; b: overweight with abdominal obesity; c: overweight without abdominal obesity; d: overweight with abdominal obesity 
 
1 
 
Supplemental Table 1. HR and 95% CI for risk of colorectal adenocarcinoma in relation to anthropometric characteristics 
Anthropometric indices 
Colorectal adenocarcinoma by anatomical location
a 
Total Proximal colon Distal colon Rectum 
  HR(95%CI)   HR(95%CI)   HR(95%CI)   HR(95%CI) 
Total 2044 
 
853 
 
606 
 
 
555 
Waist to hip ratio (WHR, continuous, per 1/10) 
     
   Not adjusted for BMI 2043 1.14(1.06-1.22) 853 1.28(1.16-1.42) 605 1.20(1.06-1.36) 555 1.15(1.01-1.31) 
Adjusted for BMI 2043 1.22(1.13-1.31) 853 1.30 (1.16-1.46) 605 1.19(1.03-1.36) 555 1.13(0.97-1.31) 
  
 
   
 
  
Waist to height ratio (WHtR, continuous, per 1/10) 
     
   Not adjusted for BMI 2044 1.14(1.06-1.22) 853 1.18(1.06-1.31) 606 1.12(0.99-1.27) 555 1.13(0.98-1.29) 
Adjusted for BMI 2044 1.15(1.03-1.28) 853 1.26(1.07-1.49) 606 1.08(0.88-1.32) 555 1.10(0.891.36) 
         
Not adjusted for BMI 
     
   <0.5 596 Reference 237 Reference 177 Reference 170 Reference 
0.5- 1138 1.19(1.07-1.32) 479 1.26(1.07-1.49) 343 1.27(1.05-1.54) 303 1.06(0.87-1.30) 
≥0.6 310 1.29(1.12-1.49) 137 1.37(1.10-1.71) 86 1.30(0.99-1.70) 82 1.20(0.91-1.58) 
P value for trend 
 
0.0002 
 
0.002 
 
 0.02 
  
 
        Adjusted for BMI 
        
<0.5 596 Reference 237 Reference 177 Reference 170 Reference 
0.5- 1138 1.23(1.08-1.41) 479 1.37(1.12-1.69) 343 1.30(1.02-1.66) 303 1.04(0.81-1.34) 
≥0.6 310 1.28(1.05-1.57) 137 1.49(1.09-2.02) 86 1.27(0.87-1.84) 82 1.06(0.72-1.56) 
P value for trend 
 
0.007 
 
0.006 
 
0.13 
 
0.74 
 
   
 
  
  
Waist to height index (WHI, continuous, per 10 units) 
     
   Not adjusted for BMI 2044 1.14(1.02-1.26) 853 1.18(1.01-1.39) 606 1.07(0.88-1.30) 555 1.18(0.96-1.45) 
Adjusted for BMI 2044 1.06(0.91-1.23) 853 1.17(0.93-1.46) 606 0.90(0.68-1.20) 555 1.10(0.82-1.48) 
      
 
  
a. adjusted for education, smoking status, alcohol drinking, physical activity, family history of cancer, study center, and/or anthropometrics when appropriate, stratified by age groups. 
2 
 
 
  
Supplemental Table 2. HR and 95% CI for risk of colorectal adenocarcinoma in relation to anthropometric characteristics by genders 
Anthropometric indices 
Total Proximal colon Distal colon Rectum 
Male Female Male Female Male Female Male Female 
N HR(95%CI) N HR(95%CI) N HR(95%CI) N HR(95%CI) N HR(95%CI) N HR(95%CI) N HR(95%CI) N HR(95%CI) 
  
      
         
Waist to hip ratio (continuous, per 1/10) 
     
         
Not adjusted for BMI 1101 1.22(1.11-1.34) 942 1.21(1.10-1.33) 410 1.37(1.18-1.59) 443 1.21(1.06-1.40) 332 1.25(1.06-1.48) 289 1.16(0.97-1.39) 343 1.07(0.90-1.26) 212 1.26(1.03-1.54) 
Adjusted for BMI 1101 1.18(1.06-1.31) 942 1.24(1.11-1.37) 410 1.34(1.13-1.60) 443 1.26(1.08-1.47) 332 1.15(0.95-1.40) 289 1.20(0.98-1.46) 343 1.05(0.86-1.27) 212 1.22(0.97-1.52) 
  
 
  
 
           
Waist to height ratio (continuous, per 1/10) 
  
 
           
Not adjusted for BMI 1101 1.24(1.12-1.38) 943 1.09(0.99-1.19) 410 1.40(1.18-1.66) 443 1.08(0.94-1.23) 332 1.28(1.05-1.55) 289 1.05(0.88-1.24) 343 1.07(0.88-1.30) 212 1.20(1.00-1.45) 
Adjusted for BMI 1101 1.20(1.02-1.42) 943 1.14(0.98-1.32) 410 1.50(1.16-1.95) 443 1.17(0.95-1.45) 332 1.10(0.82-1.49) 289 1.10(0.83-1.45) 343 1.02(0.76-1.38) 212 1.16(0.85-1.57) 
                 
Not adjusted for BMI 
                
<0.5 229 Reference 367 Reference 74 Reference 163 Reference 61 Reference 116 Reference 89 Reference 81 Reference 
0.5- 700 1.20(1.03-1.40) 438 1.23(1.06-1.42) 265 1.38(1.06-1.80) 214 1.24(1.00-1.53) 224 1.50(1.12-2.01) 119 1.16(0.88-1.51) 203 0.89(0.69-1.16) 100 1.38(1.01-1.88) 
≥0.6 172 1.43(1.17-1.76) 138 1.18(0.96-1.45) 71 1.79(1.27-2.51) 66  1.14(0.84-1.53) 47 1.55(1.05-2.31) 39 1.19(0.82-1.75) 51 1.09(0.76-1.56) 31 1.33(0.86-2.05) 
P value for trend 
 
 0.0006 
 
0.03 
 
0.0007 
 
0.2 
 
0.014 
 
0.27 
 
0.85 
 
0.08 
                 
Adjusted for BMI 
                
<0.5 229 Reference 367 Reference 74 Reference 163 Reference 61 Reference 116 Reference 89 Reference 81 Reference 
0.5- 700 1.19(0.98-1.44) 438 1.32(1.09-1.59) 265 1.48(1.07-2.04) 214 1.37(1.04-1.81) 224 1.41(0.98-2.01) 119 1.26(0.89-1.79) 203 0.86(0.63-1.19) 100 1.36(0.91-2.02) 
≥0.6 172  1.26(0.95-1.67) 138 1.30(0.97-1.73) 71 1.76(1.11-2.79) 66 1.33(0.87-2.02) 47 1.20(0.71-2.04) 39 1.40(0.81-2.41) 51 0.96(0.58-1.58) 31 1.18(0.64-2.17) 
P value for trend 
 
0.1 
 
0.03 
 
0.02 
 
0.2 
 
0.4 
 
0.18 
    
 
 
       
 
       
Waist to height index (WHI, 
continuous, per 10 units)         
 
       
Not adjusted for BMI 1119 1.30(1.10-1.53) 964 1.08(0.94-1.24) 410 1.50(1.14-1.96) 447 1.07(0.88-1.31) 332 1.32(0.97-1.79) 274 0.99(0.76-1.28) 343 1.10(0.81-1.49) 213 1.30(0.98-1.71) 
Adjusted for BMI 1119 1.12 (0.89-1.42) 964 1.07(0.87-1.31) 410 1.38(0.95-2.01) 447 1.13(0.84-1.50) 332 0.98(0.64-1.49) 274 0.93(0.64-1.37) 343 1.02(0.67-1.56) 213 1.20(0.79-1.82) 
  
       
        
